NCT06639568

Brief Summary

The participants are invited to participate in a research study. It is important to the investigators that the participants first take time to read through and understand the information provided in this sheet. Nevertheless, before the participants take part in this research study, the study will be explained to the participants and the participants will be given the chance to ask questions. After the participants are properly satisfied that they understand this study, and that they wish to take part in the study, they must sign this informed consent form. The participants will be given a copy of this consent form to take home with them. Telemedicine is the use of technology for patients to communicate with doctors and healthcare professionals without visiting the hospital/clinic personally. In colorectal cancer (CRC) care, telemedicine has been suggested for post-surgery follow-up via telephone consultations and video consultation. Although telemedicine is increasingly being adopted as an alternative to long-term healthcare, little is known about the acceptability of such remote care alternatives by CRC patients in Singapore. The participants are invited because they underwent surgery for colorectal cancer 1 to 4 years ago, are Singaporean or permanent resident of Singapore and 65 years and above. As such, the investigators want to find out about the participants' knowledge, barriers and perceptions toward the use of telemedicine as an alternative to their existing CRC care.

Trial Health

87
On Track

Trial Health Score

Automated assessment based on enrollment pace, timeline, and geographic reach

Enrollment
18

participants targeted

Target at below P25 for all trials

Timeline
Completed

Started Mar 2022

Shorter than P25 for all trials

Geographic Reach
1 country

1 active site

Status
completed

Health score is calculated from publicly available data and should be used for screening purposes only.

Trial Relationships

Click on a node to explore related trials.

Study Timeline

Key milestones and dates

Study Start

First participant enrolled

March 1, 2022

Completed
9 months until next milestone

Primary Completion

Last participant's last visit for primary outcome

November 30, 2022

Completed
Same day until next milestone

Study Completion

Last participant's last visit for all outcomes

November 30, 2022

Completed
1.9 years until next milestone

First Submitted

Initial submission to the registry

October 9, 2024

Completed
6 days until next milestone

First Posted

Study publicly available on registry

October 15, 2024

Completed
Last Updated

October 16, 2024

Status Verified

October 1, 2024

Enrollment Period

9 months

First QC Date

October 9, 2024

Last Update Submit

October 12, 2024

Conditions

Keywords

telemedicineolder adultscancerpost-operative care

Outcome Measures

Primary Outcomes (1)

  • Questionnaire

    This is a qualitative study guided by a questionnaire, hence there is no objective primary outcome measure or scale that is used

    Baseline

Study Arms (1)

Interview participants

Eligibility Criteria

Age65 Years+
Sexall
Healthy VolunteersNo
Age GroupsOlder Adult (65+)
Sampling MethodNon-Probability Sample
Study Population

Study participants aged ≥65 years who had undergone surgical resection for CRC within the past 1 - 4 years at the National University Hospital in Singapore

You may qualify if:

  • Study participants aged ≥65 years who had undergone surgical resection for CRC within the past 1 - 4 years at the National University Hospital in Singapore

Contact the study team to confirm eligibility.

Sponsors & Collaborators

Study Sites (1)

National University Hospital

Singapore, 678923, Singapore

Location

MeSH Terms

Conditions

Neoplasms

Study Design

Study Type
observational
Observational Model
OTHER
Time Perspective
CROSS SECTIONAL
Sponsor Type
OTHER
Responsible Party
PRINCIPAL INVESTIGATOR
PI Title
Consultant

Study Record Dates

First Submitted

October 9, 2024

First Posted

October 15, 2024

Study Start

March 1, 2022

Primary Completion

November 30, 2022

Study Completion

November 30, 2022

Last Updated

October 16, 2024

Record last verified: 2024-10

Data Sharing

IPD Sharing
Will not share

Locations